Journal
GENE THERAPY
Volume 19, Issue 2, Pages 169-175Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/gt.2011.155
Keywords
ocular gene transfer; optogenetics; retina
Ask authors/readers for more resources
Retinitis pigmentosa (RP) refers to a diverse group of progressive, hereditary diseases of the retina that lead to incurable blindness and affect two million people worldwide. Artificial photoreceptors constructed by gene delivery of light-activated channels or pumps ('optogenetic tools') to surviving cell types in the remaining retinal circuit has been shown to restore photosensitivity in animal models of RP at the level of the retina and cortex as well as behaviorally. The translational potential of this optogenetic approach has been evaluated using in vitro studies involving post-mortem human retinas. Here, we review recent developments in this expanding field and discuss the potential and limitations of optogenetic engineering for the treatment of RP. Gene Therapy (2012) 19, 169-175; doi:10.1038/gt.2011.155; published online 13 October 2011
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available